Health sciences review (Oxford, England)最新文献_第3页

Trauma registries compared: A systemic review of the barriers, enablers, and the path to standardisation 创伤登记比较：对障碍、促成因素和标准化路径的系统回顾

Health sciences review (Oxford, England)

Pub Date : 2025-08-19 DOI: 10.1016/j.hsr.2025.100240

Adrian Crawford , Neil Ashwood , Akhshay George , Gur Aziz Singh Sidhu

National trauma registries were introduced 20 years ago to improve care of the multiply injured patients through benchmarking and accreditation of dedicated trauma centres. However, variability in registry design, lack of long-term functional outcome data has limited its use. A standardised dataset has been agreed upon, but not implemented which has made it difficult to obtain meaningful results, particularly in frail elderly populations.

This narrative synthesis aims to identify enablers of standardised data collection and reporting, that improves care within all levels of hospitalised trauma patients. Eligible studies were identified through systematic searches of Medline, EMBASE, and PsycINFO databases using a comprehensive algorithm designed to maximise sensitivity. Registry websites, annual reports, and data dictionaries were also reviewed. Two researchers independently screened studies extracted data on barriers and enablers, and assessed study quality using the Methodological Index for Non-Randomised Studies (MINORS). A thematic analysis was conducted to synthesise findings.

Barriers to effective registry included inconsistent funding, limited infrastructure and exclusion of high-risk groups, such as elderly. Enablers included government mandates, standardised methods and broad inclusion criteria. While many registries demonstrated improved mortality tracking and injury prevention strategies, very few captured long-term disability outcomes or needs of elderly patients.

Trauma care requires standardised registries with comparable datasets to enable benchmarking and improve outcomes focussed on recovery from the long-term impacts of trauma, particularly among frail elderly populations. Collaboration between trauma registries of all levels is essential to develop robust systems that drive meaningful changes in practice worldwide.

国家创伤登记处是在20年前引入的，通过对专门的创伤中心进行基准测试和认证，以改善对众多受伤患者的护理。然而，注册表设计的可变性和长期功能结果数据的缺乏限制了其应用。标准化数据集已经达成一致，但尚未实施，这使得难以获得有意义的结果，特别是在体弱的老年人群中。这种叙事综合旨在确定标准化数据收集和报告的推动因素，从而改善住院创伤患者的各级护理。通过对Medline、EMBASE和PsycINFO数据库的系统搜索，使用旨在最大化灵敏度的综合算法来确定符合条件的研究。还审查了登记处网站、年度报告和数据字典。两名研究人员独立筛选研究，提取障碍和促进因素的数据，并使用非随机研究方法学指数（未成年人）评估研究质量。进行了专题分析以综合调查结果。有效登记的障碍包括资金不一致、基础设施有限以及排除老年人等高风险群体。促成因素包括政府命令、标准化方法和广泛的纳入标准。虽然许多登记显示了改进的死亡率跟踪和伤害预防策略，但很少有记录到老年患者的长期残疾结果或需求。创伤护理需要具有可比较数据集的标准化注册，以实现基准和改善侧重于从创伤的长期影响中恢复的结果，特别是在体弱的老年人群中。各级创伤登记机构之间的合作对于开发强大的系统，推动全球实践中有意义的变革至关重要。

{"title":"Trauma registries compared: A systemic review of the barriers, enablers, and the path to standardisation","authors":"Adrian Crawford , Neil Ashwood , Akhshay George , Gur Aziz Singh Sidhu","doi":"10.1016/j.hsr.2025.100240","DOIUrl":"10.1016/j.hsr.2025.100240","url":null,"abstract":"<div><div>National trauma registries were introduced 20 years ago to improve care of the multiply injured patients through benchmarking and accreditation of dedicated trauma centres. However, variability in registry design, lack of long-term functional outcome data has limited its use. A standardised dataset has been agreed upon, but not implemented which has made it difficult to obtain meaningful results, particularly in frail elderly populations.</div><div>This narrative synthesis aims to identify enablers of standardised data collection and reporting, that improves care within all levels of hospitalised trauma patients. Eligible studies were identified through systematic searches of Medline, EMBASE, and PsycINFO databases using a comprehensive algorithm designed to maximise sensitivity. Registry websites, annual reports, and data dictionaries were also reviewed. Two researchers independently screened studies extracted data on barriers and enablers, and assessed study quality using the Methodological Index for Non-Randomised Studies (MINORS). A thematic analysis was conducted to synthesise findings.</div><div>Barriers to effective registry included inconsistent funding, limited infrastructure and exclusion of high-risk groups, such as elderly. Enablers included government mandates, standardised methods and broad inclusion criteria. While many registries demonstrated improved mortality tracking and injury prevention strategies, very few captured long-term disability outcomes or needs of elderly patients.</div><div>Trauma care requires standardised registries with comparable datasets to enable benchmarking and improve outcomes focussed on recovery from the long-term impacts of trauma, particularly among frail elderly populations. Collaboration between trauma registries of all levels is essential to develop robust systems that drive meaningful changes in practice worldwide.</div></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"17 ","pages":"Article 100240"},"PeriodicalIF":0.0,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145018433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clay minerals used in formulations for cutaneous wound healing: An educational review 用于皮肤伤口愈合配方的粘土矿物：教育回顾

Health sciences review (Oxford, England)

Pub Date : 2025-08-18 DOI: 10.1016/j.hsr.2025.100242

Paligwendé Anne Marie Kaboré , Raogo Ouédraogo , Bavouma Charles Sombié , Zakaline Yabré , Rasmané Semdé

In recent years, the use of clay minerals in wound treatment has been the subject of extensive researches. The present paper aimed to review studies on clay minerals-based formulations for the treatment of cutaneous wounds, highlighting the healing properties attributable to the addition of these minerals in formulations. A review of literature was conducted using the ScienceDirect, Scopus, and PubMed databases to identify research articles evaluating the wound-healing properties of clay mineral-based formulations. Studies reporting positive outcomes were included. Sixty-three (63) research articles were analyzed. The most commonly used minerals were halloysite nanotubes and montmorillonite. The less commonly used ones included bentonite, laponite, sepiolite, kaolinite, hectorite and palygorskite. In most cases, these minerals were combined with active ingredients such as antibacterials and dispersed in polymeric matrices. The identified pharmaceutical included films, hydrogels, electrospun nanofibers, sponge forms, membranes, powders, patches and creams. The results showed that clay minerals not only improved the mechanical and physical properties of the formulations, but also contributed to wound healing. Their presence accelerated hemostasis, reduced inflammation, stimulated cell proliferation and enhanced tissue remodeling. Furthermore, they potentiated and/or prolonged antibacterial activity, which is crucial for wound healing. Generally, these benefits are closed linked to the inherent physical and chemical properties of the clay minerals. Among clays minerals, halloysite and montmorillonite are of considerable interest in wound management for their proven healing properties. Their abundance in nature, biocompatibility and low cost make them a viable choice for effective wound management.

近年来，粘土矿物在伤口治疗中的应用得到了广泛的研究。本文旨在回顾粘土矿物为基础的配方治疗皮肤伤口的研究，强调愈合性能归因于添加这些矿物质的配方。使用ScienceDirect、Scopus和PubMed数据库进行文献回顾，以确定评估粘土矿物基配方伤口愈合特性的研究文章。报告阳性结果的研究被纳入。分析了63篇研究论文。最常用的矿物是高岭土、纳米管和蒙脱土。较不常用的有膨润土、拉脱土、海泡石、高岭土、海长石和斜长石。在大多数情况下，这些矿物质与抗菌药物等活性成分结合，分散在聚合物基质中。被鉴定的药物包括薄膜、水凝胶、电纺纳米纤维、海绵、膜、粉末、贴剂和面霜。结果表明，黏土矿物不仅改善了配方的力学和物理性能，而且有助于伤口愈合。它们的存在加速了止血，减少了炎症，刺激了细胞增殖，增强了组织重塑。此外，它们增强和/或延长抗菌活性，这对伤口愈合至关重要。一般来说，这些好处与粘土矿物固有的物理和化学性质密切相关。在粘土矿物中，高岭土和蒙脱土因其已证实的愈合特性而在伤口管理中引起了相当大的兴趣。其丰富的性质、生物相容性和低成本使其成为有效伤口管理的可行选择。

{"title":"Clay minerals used in formulations for cutaneous wound healing: An educational review","authors":"Paligwendé Anne Marie Kaboré , Raogo Ouédraogo , Bavouma Charles Sombié , Zakaline Yabré , Rasmané Semdé","doi":"10.1016/j.hsr.2025.100242","DOIUrl":"10.1016/j.hsr.2025.100242","url":null,"abstract":"<div><div>In recent years, the use of clay minerals in wound treatment has been the subject of extensive researches. The present paper aimed to review studies on clay minerals-based formulations for the treatment of cutaneous wounds, highlighting the healing properties attributable to the addition of these minerals in formulations. A review of literature was conducted using the ScienceDirect, Scopus, and PubMed databases to identify research articles evaluating the wound-healing properties of clay mineral-based formulations. Studies reporting positive outcomes were included. Sixty-three (63) research articles were analyzed. The most commonly used minerals were halloysite nanotubes and montmorillonite. The less commonly used ones included bentonite, laponite, sepiolite, kaolinite, hectorite and palygorskite. In most cases, these minerals were combined with active ingredients such as antibacterials and dispersed in polymeric matrices. The identified pharmaceutical included films, hydrogels, electrospun nanofibers, sponge forms, membranes, powders, patches and creams. The results showed that clay minerals not only improved the mechanical and physical properties of the formulations, but also contributed to wound healing. Their presence accelerated hemostasis, reduced inflammation, stimulated cell proliferation and enhanced tissue remodeling. Furthermore, they potentiated and/or prolonged antibacterial activity, which is crucial for wound healing. Generally, these benefits are closed linked to the inherent physical and chemical properties of the clay minerals. Among clays minerals, halloysite and montmorillonite are of considerable interest in wound management for their proven healing properties. Their abundance in nature, biocompatibility and low cost make them a viable choice for effective wound management.</div></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"17 ","pages":"Article 100242"},"PeriodicalIF":0.0,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144902590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Utility of the New York heart association functional classification compared to other measures: A systematic review 与其他指标相比，纽约心脏协会功能分类的效用：一项系统综述

Health sciences review (Oxford, England)

Pub Date : 2025-08-17 DOI: 10.1016/j.hsr.2025.100241

Kelly D. Stamp , Marilyn A. Prasun , Thomas P. McCoy , Lisa Rathman

This systematic review comprised of an assessment of the relevant literature for measures that were most similar to the New York Heart Association Functional Classification. Additionally, we assessed whether those measures compared in accuracy with the New York Heart Association Functional Classification when assigning the functional class of patients with heart failure. The review included seven articles that met the inclusion and exclusion criteria. Our findings were that New York Heart Association Functional Classification was predictive of functional limitations in patients with heart failure with reduced ejection fraction when compared to other measures. However, there was limited evidence to support the predictive ability of New York Heart Association Functional Classification in patients with heart failure with preserved ejection fraction. A more objective way to improve accuracy of New York Heart Association Functional Classification could be to assign metabolic equivalent levels to each functional class.

For future directions, a clear objective definition of functional class that is in alignment with the associated symptoms is needed to ensure consistent assignment. In addition, further testing of the New York Heart Association Functional Classification in patients with heart failure with preserved ejection fraction with reproducibility is warranted.

该系统综述包括对与纽约心脏协会功能分类最相似的相关文献的评估。此外，我们评估了在分配心力衰竭患者的功能类别时，这些测量是否与纽约心脏协会功能分类的准确性相比较。该综述包括7篇符合纳入和排除标准的文章。我们的研究结果是，与其他指标相比，纽约心脏协会功能分级可预测射血分数降低的心力衰竭患者的功能限制。然而，支持纽约心脏协会功能分级对保留射血分数的心力衰竭患者的预测能力的证据有限。提高纽约心脏协会功能分类准确性的一种更客观的方法可能是为每个功能类别分配代谢当量水平。对于未来的方向，需要一个与相关症状相一致的清晰客观的功能分类定义，以确保分配的一致性。此外，纽约心脏协会功能分类在保留射血分数的心力衰竭患者中的进一步测试具有可重复性是有必要的。

{"title":"Utility of the New York heart association functional classification compared to other measures: A systematic review","authors":"Kelly D. Stamp , Marilyn A. Prasun , Thomas P. McCoy , Lisa Rathman","doi":"10.1016/j.hsr.2025.100241","DOIUrl":"10.1016/j.hsr.2025.100241","url":null,"abstract":"<div><div>This systematic review comprised of an assessment of the relevant literature for measures that were most similar to the New York Heart Association Functional Classification. Additionally, we assessed whether those measures compared in accuracy with the New York Heart Association Functional Classification when assigning the functional class of patients with heart failure. The review included seven articles that met the inclusion and exclusion criteria. Our findings were that New York Heart Association Functional Classification was predictive of functional limitations in patients with heart failure with reduced ejection fraction when compared to other measures. However, there was limited evidence to support the predictive ability of New York Heart Association Functional Classification in patients with heart failure with preserved ejection fraction. A more objective way to improve accuracy of New York Heart Association Functional Classification could be to assign metabolic equivalent levels to each functional class.</div><div>For future directions, a clear objective definition of functional class that is in alignment with the associated symptoms is needed to ensure consistent assignment. In addition, further testing of the New York Heart Association Functional Classification in patients with heart failure with preserved ejection fraction with reproducibility is warranted.</div></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"17 ","pages":"Article 100241"},"PeriodicalIF":0.0,"publicationDate":"2025-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144891844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Psychosis secondary to thyrotoxicosis: An educational review 甲状腺毒症继发精神疾病：教育回顾

Health sciences review (Oxford, England)

Pub Date : 2025-07-08 DOI: 10.1016/j.hsr.2025.100237

Hana Taha , Salma Abdel Wahed , Vanja Berggren

Excess thyroid hormones have a major effect on brain metabolism and neurotransmitter systems. This study aimed to examine the complex relationship between thyrotoxicosis and psychosis including symptoms and treatment options. This literature review summarized 37 case reports of psychosis secondary to thyrotoxicosis that were published in PubMed, Medline, Web of Science and Google Scholar searches between Jan 2011 and Dec 2024. The results indicated that the case reports of females were significantly more than those of males. The most common psychiatric symptom was agitation (27.02 %) while mania and psychomotor agitation were the least common one (2.7 %). For thyrotoxicosis symptoms, tachycardia (32.43 %) was the most frequently mentioned symptom, and the least common ones were goiter and high blood pressure (13.51 %). The findings of this review emphasize the value of collaborative treatment combining psychiatrist and endocrinologist to address the complex clinical presentations and treatment modalities.

过量的甲状腺激素对脑代谢和神经递质系统有重大影响。本研究旨在探讨甲状腺毒症与精神病之间的复杂关系，包括症状和治疗方案。本文献综述总结了2011年1月至2024年12月间发表在PubMed、Medline、Web of Science和谷歌Scholar搜索上的37例甲状腺毒症继发精神病报告。结果表明，女性病例报告明显多于男性病例报告。最常见的精神症状是躁动（27.02%），最不常见的是躁狂和精神运动性躁动（2.7%）。在甲状腺毒症症状中，最常被提及的是心动过速（32.43%），最不常见的是甲状腺肿和高血压（13.51%）。本综述的研究结果强调精神病学家和内分泌学家合作治疗的价值，以解决复杂的临床表现和治疗方式。

引用次数: 0

Decoding Brugada syndrome: A comprehensive analysis of pathophysiology, genetic foundations and advanced clinical management 解码Brugada综合征：病理生理学、遗传学基础和先进临床管理的综合分析

Health sciences review (Oxford, England)

Pub Date : 2025-07-07 DOI: 10.1016/j.hsr.2025.100238

Aman Kumar , Junaid Tantray , Sourabh Kosey , Chingtham Henthoibi Devi , Bhupendra Prajapati

Background

Sudden cardiac death is linked to the hereditary condition known as Brugada syndrome (BrS), an autosomal dominant heart illness. Another name for it is sudden nocturnal death syndrome, a novel arrhythmogenic condition that has drawn attention because of its intricate pathophysiology and potential medical applications. BrS is generally considered a fairly uncommon condition, with an estimated 0.05 % global frequency and 0.4 % pattern. The reported prevalence of BrS ranges from 1 in 2000 to 1 in 5000.

Objective

This study seeks to provide a complete understanding of the pathophysiology, genetic basis, diagnostic criteria, and treatment methods related to Brugada syndrome.

Methods

A narrative synthesis of current research was undertaken, concentrating on epidemiology, electrophysiological processes, genetic alterations (specifically SCN5A), and clinical management techniques, including risk stratification tools and treatment modalities.

Results

BrS has a worldwide prevalence estimated between 1 in 2000 and 1 in 5000 persons. Genetic mutations, especially affecting heart sodium channels, provide an arrhythmogenic substrate resulting in distinctive ECG abnormalities. Diagnosis is driven by revised clinical criteria and electrophysiological results. Management involves the use of implanted cardioverter-defibrillators (ICDs) and medication. Recent findings have clarified genotype-phenotype connections and enhanced patient risk classification

Conclusion

Brugada syndrome is a complicated cardiac illness needing standardized diagnostic techniques and specialized therapeutic options. Future research should concentrate on enhancing genetic screening, risk prediction models, and the development of tailored medicines to lower sudden cardiac death risk.

背景心源性猝死与一种常染色体显性心脏病Brugada综合征（BrS）有关。它的另一个名称是夜间猝死综合征，这是一种新的心律失常疾病，由于其复杂的病理生理和潜在的医学应用而引起了人们的关注。BrS通常被认为是一种相当罕见的疾病，估计全球频率为0.05%，模式为0.4%。报告的BrS患病率从2000年的1 / 5000到1 / 5000不等。目的全面了解Brugada综合征的病理生理、遗传基础、诊断标准和治疗方法。方法对目前的研究进行叙述性综合，重点是流行病学、电生理过程、遗传改变（特别是SCN5A）和临床管理技术，包括风险分层工具和治疗方式。结果brs在世界范围内的患病率估计在2000 / 1至5000 / 1之间。基因突变，尤其是影响心脏钠通道的基因突变，提供了致心律失常的底物，导致独特的ECG异常。诊断是由修订的临床标准和电生理结果驱动的。治疗包括使用植入式心律转复除颤器（icd）和药物治疗。结论brugada综合征是一种复杂的心脏疾病，需要标准化的诊断技术和专门的治疗方案。未来的研究应集中在加强基因筛查、风险预测模型和开发量身定制的药物来降低心源性猝死风险。

{"title":"Decoding Brugada syndrome: A comprehensive analysis of pathophysiology, genetic foundations and advanced clinical management","authors":"Aman Kumar , Junaid Tantray , Sourabh Kosey , Chingtham Henthoibi Devi , Bhupendra Prajapati","doi":"10.1016/j.hsr.2025.100238","DOIUrl":"10.1016/j.hsr.2025.100238","url":null,"abstract":"<div><h3>Background</h3><div>Sudden cardiac death is linked to the hereditary condition known as Brugada syndrome (BrS), an autosomal dominant heart illness. Another name for it is sudden nocturnal death syndrome, a novel arrhythmogenic condition that has drawn attention because of its intricate pathophysiology and potential medical applications. BrS is generally considered a fairly uncommon condition, with an estimated 0.05 % global frequency and 0.4 % pattern. The reported prevalence of BrS ranges from 1 in 2000 to 1 in 5000.</div></div><div><h3>Objective</h3><div>This study seeks to provide a complete understanding of the pathophysiology, genetic basis, diagnostic criteria, and treatment methods related to Brugada syndrome.</div></div><div><h3>Methods</h3><div>A narrative synthesis of current research was undertaken, concentrating on epidemiology, electrophysiological processes, genetic alterations (specifically SCN5A), and clinical management techniques, including risk stratification tools and treatment modalities.</div></div><div><h3>Results</h3><div>BrS has a worldwide prevalence estimated between 1 in 2000 and 1 in 5000 persons. Genetic mutations, especially affecting heart sodium channels, provide an arrhythmogenic substrate resulting in distinctive ECG abnormalities. Diagnosis is driven by revised clinical criteria and electrophysiological results. Management involves the use of implanted cardioverter-defibrillators (ICDs) and medication. Recent findings have clarified genotype-phenotype connections and enhanced patient risk classification</div></div><div><h3>Conclusion</h3><div>Brugada syndrome is a complicated cardiac illness needing standardized diagnostic techniques and specialized therapeutic options. Future research should concentrate on enhancing genetic screening, risk prediction models, and the development of tailored medicines to lower sudden cardiac death risk.</div></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"16 ","pages":"Article 100238"},"PeriodicalIF":0.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144679665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Efficacy of bimatoprost sustained-release implant in treating severe intraocular pressure in open glaucoma: A meta-analysis 比马前列素缓释植入治疗开放性青光眼严重眼压的疗效：一项荟萃分析

Health sciences review (Oxford, England)

Pub Date : 2025-07-05 DOI: 10.1016/j.hsr.2025.100235

Saad Mutlaq Alosaimi , Ahmad Al Habash , Shahad Salah Alsubhi (Literature Search)

This meta-analysis investigates the efficacy and safety of the bimatoprost sustained-release (SR) implant for reducing intraocular pressure (IOP) in patients with open-angle glaucoma (OAG), particularly those with severe or uncontrolled IOP. A comprehensive search of multiple databases identified twelve randomized controlled trials including a total of 2808 patients. Pooled analysis demonstrated that the bimatoprost SR implant significantly reduced IOP compared to placebo, with a mean difference of –1.53 mmHg. The implant also increased the proportion of patients achieving desired IOP reduction and was associated with a modest improvement in rescue rates. Adverse events were generally low, with no treatment-emergent adverse events reported in the intervention group. These findings suggest that the bimatoprost SR implant is a safe and effective alternative for patients with OAG who may struggle with adherence to daily eye drops. Further studies are recommended to evaluate its long-term impact on disease progression and visual outcomes.

本荟萃分析探讨了比马前列素缓释（SR）植入物降低开角型青光眼（OAG）患者眼压（IOP）的有效性和安全性，特别是那些严重或不受控制的眼压患者。对多个数据库进行综合检索，确定了12项随机对照试验，共2808例患者。合并分析表明，与安慰剂相比，比马前列素SR植入物可显著降低IOP，平均差值为-1.53 mmHg。植入物还增加了达到预期IOP降低的患者比例，并与抢救率的适度改善相关。不良事件普遍较低，干预组无治疗后出现的不良事件报告。这些发现表明，对于那些可能难以坚持每日滴眼液的OAG患者来说，比马前列素SR植入物是一种安全有效的选择。建议进一步研究评估其对疾病进展和视力结果的长期影响。

{"title":"Efficacy of bimatoprost sustained-release implant in treating severe intraocular pressure in open glaucoma: A meta-analysis","authors":"Saad Mutlaq Alosaimi , Ahmad Al Habash , Shahad Salah Alsubhi (Literature Search)","doi":"10.1016/j.hsr.2025.100235","DOIUrl":"10.1016/j.hsr.2025.100235","url":null,"abstract":"<div><div>This meta-analysis investigates the efficacy and safety of the bimatoprost sustained-release (SR) implant for reducing intraocular pressure (IOP) in patients with open-angle glaucoma (OAG), particularly those with severe or uncontrolled IOP. A comprehensive search of multiple databases identified twelve randomized controlled trials including a total of 2808 patients. Pooled analysis demonstrated that the bimatoprost SR implant significantly reduced IOP compared to placebo, with a mean difference of –1.53 mmHg. The implant also increased the proportion of patients achieving desired IOP reduction and was associated with a modest improvement in rescue rates. Adverse events were generally low, with no treatment-emergent adverse events reported in the intervention group. These findings suggest that the bimatoprost SR implant is a safe and effective alternative for patients with OAG who may struggle with adherence to daily eye drops. Further studies are recommended to evaluate its long-term impact on disease progression and visual outcomes.</div></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"16 ","pages":"Article 100235"},"PeriodicalIF":0.0,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144604500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Driving and sustaining trauma-informed organizational change: The role of healthcare leadership 推动和维持创伤知情的组织变革：医疗保健领导的作用

Health sciences review (Oxford, England)

Pub Date : 2025-06-24 DOI: 10.1016/j.hsr.2025.100236

Amidu Alhassan , Sana Rasheed , Ahmed Asad Raza , Bushra Murtaza , Azka Mujeeb , Ayesha Iqbal Mansoor

Trauma is a major public health concern, both omnipresent and burdensome. Trauma-informed care [TIC] is regarded as a multilevel approach that alters the way organizations perceive and address trauma. TIC has shown a beneficial impact on patient health, employee well-being, and institutional performance. Efforts to implement TIC necessitate leadership backing and the establishment of policies to guarantee consistent application. This review examines the implementation and sustainability of TIC in healthcare, focusing on its principles, role of leadership, challenges, and strategies. It aims to provide insights to enhance patient outcomes, support staff well-being, and foster a trauma-informed healthcare culture. TIC is a well-established framework for supporting trauma survivors and improving outcomes in emergency departments. Studies have shown that implementing TIC education programs can reduce the number of patients subjected to physical restraints and the overall time spent in restraints. Strategic leaders must develop standardized policies to guide the change process. Staff trained under certified programs provide better results in trauma-informed healthcare by influencing their knowledge, behavior, and beliefs. Organizational challenges include the need for repeated training and ongoing support. Community clinics face time constraints in consultations, financial constraints, and high patient turnover. Sustaining trauma-informed change requires systemic strategies that prioritize safety, empowerment, and collaboration. Supportive leadership empowers employees through shared decision-making and continuous training. Embedding TIC into organizational policies ensures sustainability by promoting safety, equity, and inclusivity. Future research should evaluate and refine TIC practices to build a stronger evidence base.

创伤是一个主要的公共卫生问题，既无所不在，又令人负担沉重。创伤知情护理（TIC）被认为是一种多层次的方法，它改变了组织感知和处理创伤的方式。TIC已显示出对患者健康、员工福利和机构绩效的有益影响。实施投资管理的努力需要领导的支持和政策的制定，以确保一致的应用。本文综述了TIC在医疗保健中的实施和可持续性，重点是其原则、领导作用、挑战和策略。它旨在提供见解，以提高患者的结果，支持工作人员的福祉，并促进创伤知情的医疗保健文化。TIC是一个完善的框架，用于支持创伤幸存者和改善急诊科的结果。研究表明，实施TIC教育计划可以减少患者受到身体限制的数量和在限制中花费的总时间。战略领导者必须制定标准化的政策来指导变革过程。经过认证项目培训的员工通过影响他们的知识、行为和信仰，在创伤知情医疗保健方面取得了更好的结果。组织方面的挑战包括需要反复培训和持续支持。社区诊所面临着时间限制、资金限制和病人高流动率的问题。维持创伤知情的改变需要优先考虑安全、授权和协作的系统性战略。支持性领导通过共同决策和持续培训来授权员工。将TIC纳入组织政策，通过促进安全、公平和包容，确保可持续发展。未来的研究应评估和完善TIC实践，以建立更有力的证据基础。

{"title":"Driving and sustaining trauma-informed organizational change: The role of healthcare leadership","authors":"Amidu Alhassan , Sana Rasheed , Ahmed Asad Raza , Bushra Murtaza , Azka Mujeeb , Ayesha Iqbal Mansoor","doi":"10.1016/j.hsr.2025.100236","DOIUrl":"10.1016/j.hsr.2025.100236","url":null,"abstract":"<div><div>Trauma is a major public health concern, both omnipresent and burdensome. Trauma-informed care [TIC] is regarded as a multilevel approach that alters the way organizations perceive and address trauma. TIC has shown a beneficial impact on patient health, employee well-being, and institutional performance. Efforts to implement TIC necessitate leadership backing and the establishment of policies to guarantee consistent application. This review examines the implementation and sustainability of TIC in healthcare, focusing on its principles, role of leadership, challenges, and strategies. It aims to provide insights to enhance patient outcomes, support staff well-being, and foster a trauma-informed healthcare culture. TIC is a well-established framework for supporting trauma survivors and improving outcomes in emergency departments. Studies have shown that implementing TIC education programs can reduce the number of patients subjected to physical restraints and the overall time spent in restraints. Strategic leaders must develop standardized policies to guide the change process. Staff trained under certified programs provide better results in trauma-informed healthcare by influencing their knowledge, behavior, and beliefs. Organizational challenges include the need for repeated training and ongoing support. Community clinics face time constraints in consultations, financial constraints, and high patient turnover. Sustaining trauma-informed change requires systemic strategies that prioritize safety, empowerment, and collaboration. Supportive leadership empowers employees through shared decision-making and continuous training. Embedding TIC into organizational policies ensures sustainability by promoting safety, equity, and inclusivity. Future research should evaluate and refine TIC practices to build a stronger evidence base.</div></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"16 ","pages":"Article 100236"},"PeriodicalIF":0.0,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144513523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A surgeon’s primer on Unique Device Identifier (UDI) capture: Where do we stand on implant surveillance and how can we improve? 外科医生对唯一设备标识符（UDI）捕获的入门：我们在植入物监测方面处于什么位置？我们如何改进？

Health sciences review (Oxford, England)

Pub Date : 2025-06-10 DOI: 10.1016/j.hsr.2025.100234

Alberto Jarrin Lopez , Amartya Dave , Tejas Sathe , Hanmin Lee

The Unique Device Identifier (UDI) system was developed to improve the identification and tracking of medical devices throughout their lifecycle. Despite its potential to enhance patient outcomes, streamline supply chain management, and facilitate swift responses to device recalls, widespread adoption remains limited. In the absence of regulatory policies enforcing standardized UDI practices, this paper underscores the critical role surgeons play in implementing and advocating for UDI’s utility within their institutions. By reviewing published roadmaps and playbooks, we highlight key steps for successful adoption. We examine case studies from early adopter institutions—Mercy Health, Duke University Health System, and Kaiser Permanente—that have successfully integrated UDI systems, demonstrating tangible benefits. Recognizing the barriers to nationwide UDI implementation as well as the unique role of surgeons at the intersection of patient care and device innovation, we conclude by proposing practical, actionable steps for surgeons to drive change within their institution.

唯一设备标识符（UDI）系统的开发是为了改善医疗设备在其整个生命周期中的识别和跟踪。尽管它有可能提高患者的治疗效果，简化供应链管理，并促进对设备召回的快速反应，但广泛采用仍然有限。在缺乏执行标准化UDI实践的监管政策的情况下，本文强调了外科医生在实施和倡导UDI在其机构内的效用方面发挥的关键作用。通过回顾已出版的路线图和剧本，我们强调了成功采用的关键步骤。我们研究了早期采用UDI系统的机构的案例研究——mercy Health、杜克大学卫生系统和Kaiser permanente——这些机构成功地整合了UDI系统，并展示了切实的好处。认识到在全国范围内实施UDI的障碍，以及外科医生在患者护理和设备创新的交叉点上的独特作用，我们提出了外科医生在其机构内推动变革的实际、可操作的步骤。

{"title":"A surgeon’s primer on Unique Device Identifier (UDI) capture: Where do we stand on implant surveillance and how can we improve?","authors":"Alberto Jarrin Lopez , Amartya Dave , Tejas Sathe , Hanmin Lee","doi":"10.1016/j.hsr.2025.100234","DOIUrl":"10.1016/j.hsr.2025.100234","url":null,"abstract":"<div><div>The Unique Device Identifier (UDI) system was developed to improve the identification and tracking of medical devices throughout their lifecycle. Despite its potential to enhance patient outcomes, streamline supply chain management, and facilitate swift responses to device recalls, widespread adoption remains limited. In the absence of regulatory policies enforcing standardized UDI practices, this paper underscores the critical role surgeons play in implementing and advocating for UDI’s utility within their institutions. By reviewing published roadmaps and playbooks, we highlight key steps for successful adoption. We examine case studies from early adopter institutions—Mercy Health, Duke University Health System, and Kaiser Permanente—that have successfully integrated UDI systems, demonstrating tangible benefits. Recognizing the barriers to nationwide UDI implementation as well as the unique role of surgeons at the intersection of patient care and device innovation, we conclude by proposing practical, actionable steps for surgeons to drive change within their institution.</div></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"16 ","pages":"Article 100234"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144263803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Advances in the understanding and management of multiple sclerosis phenotypes 多发性硬化症表型的认识和治疗进展

Health sciences review (Oxford, England)

Pub Date : 2025-06-10 DOI: 10.1016/j.hsr.2025.100232

Ali Msheik, Zeinab Al Mokdad, Reem Hmede, Rami Atat

Multiple sclerosis is a chronic autoimmune disease of the central nervous system characterized by inflammation, demyelination, and neurodegeneration. This review synthesizes current understanding of multiple sclerosis subtypes, diagnostic criteria, and the evolving landscape of therapeutic strategies. It highlights advances in imaging modalities and biomarkers that enhance disease characterization and monitoring. Clinically isolated syndrome and radiologically isolated syndrome are recognized as early indicators of multiple sclerosis, with specific magnetic resonance imaging features and cerebrospinal fluid findings aiding in diagnosis and prognosis. Relapsing-remitting multiple sclerosis remains the most prevalent form, with many patients eventually progressing to secondary progressive multiple sclerosis. Primary progressive multiple sclerosis presents unique diagnostic and therapeutic challenges. Recent years have seen a shift toward early aggressive therapy, with monoclonal antibodies like ocrelizumab and ofatumumab demonstrating significant efficacy in reducing disease activity. New oral agents and autologous hematopoietic stem cell transplantation show promise, particularly in refractory or highly active cases. Siponimod and other selective S1P modulators are emerging as treatments for active SPMS, though therapeutic options for non-active progressive forms remain limited. Biomarkers such as neurofilament light are under investigation for their roles in early detection, subtype differentiation, and monitoring disease progression. This review underscores the growing role of precision medicine in multiple sclerosis, driven by improved diagnostics, individualized treatment approaches, and novel therapeutic targets

多发性硬化症是一种中枢神经系统慢性自身免疫性疾病，以炎症、脱髓鞘和神经退行性变为特征。这篇综述综合了目前对多发性硬化症亚型、诊断标准和不断发展的治疗策略的理解。它强调了增强疾病表征和监测的成像方式和生物标志物的进步。临床孤立综合征和影像学孤立综合征被认为是多发性硬化症的早期指标，特殊的磁共振成像特征和脑脊液发现有助于诊断和预后。复发缓解型多发性硬化仍然是最常见的形式，许多患者最终进展为继发性进行性多发性硬化。原发性进行性多发性硬化提出了独特的诊断和治疗挑战。近年来，随着单克隆抗体（如ocrelizumab和ofatumumab）在降低疾病活动性方面显示出显着的疗效，人们开始转向早期积极治疗。新的口服药物和自体造血干细胞移植显示出希望，特别是在难治性或高度活跃的病例中。Siponimod和其他选择性S1P调节剂正在成为治疗活动性SPMS的新方法，尽管非活动性进展型SPMS的治疗选择仍然有限。神经丝光等生物标志物在早期检测、亚型分化和监测疾病进展中的作用正在研究中。这篇综述强调了精准医学在多发性硬化症中越来越重要的作用，这是由改进的诊断、个性化的治疗方法和新的治疗靶点所驱动的

{"title":"Advances in the understanding and management of multiple sclerosis phenotypes","authors":"Ali Msheik, Zeinab Al Mokdad, Reem Hmede, Rami Atat","doi":"10.1016/j.hsr.2025.100232","DOIUrl":"10.1016/j.hsr.2025.100232","url":null,"abstract":"<div><div>Multiple sclerosis is a chronic autoimmune disease of the central nervous system characterized by inflammation, demyelination, and neurodegeneration. This review synthesizes current understanding of multiple sclerosis subtypes, diagnostic criteria, and the evolving landscape of therapeutic strategies. It highlights advances in imaging modalities and biomarkers that enhance disease characterization and monitoring. Clinically isolated syndrome and radiologically isolated syndrome are recognized as early indicators of multiple sclerosis, with specific magnetic resonance imaging features and cerebrospinal fluid findings aiding in diagnosis and prognosis. Relapsing-remitting multiple sclerosis remains the most prevalent form, with many patients eventually progressing to secondary progressive multiple sclerosis. Primary progressive multiple sclerosis presents unique diagnostic and therapeutic challenges. Recent years have seen a shift toward early aggressive therapy, with monoclonal antibodies like ocrelizumab and ofatumumab demonstrating significant efficacy in reducing disease activity. New oral agents and autologous hematopoietic stem cell transplantation show promise, particularly in refractory or highly active cases. Siponimod and other selective S1P modulators are emerging as treatments for active SPMS, though therapeutic options for non-active progressive forms remain limited. Biomarkers such as neurofilament light are under investigation for their roles in early detection, subtype differentiation, and monitoring disease progression. This review underscores the growing role of precision medicine in multiple sclerosis, driven by improved diagnostics, individualized treatment approaches, and novel therapeutic targets</div></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"16 ","pages":"Article 100232"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144255283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

How is professionalism measured in health care professions? 如何衡量卫生保健专业的专业性？

Health sciences review (Oxford, England)

Pub Date : 2025-05-19 DOI: 10.1016/j.hsr.2025.100224

Anas Alnasser , Brett Williams , Cameron M Gosling

This scoping study aims to explore the available literature, key concepts, and strategic approaches for measuring professionalism in the health sector. The central research question is: How is professionalism evaluated across various healthcare fields?

Professionalism is essential for quality care and trust within healthcare institutions. Understanding how it is measured can enhance healthcare delivery.

This review was conducted following the JBI approach and adhering to PRISMA-ScR guidelines.

Electronic databases were systematically searched for articles published between 2005 and 2024. A total of 1,558 articles were identified, and after screening titles and abstracts, 44 papers were included for analysis.

The review revealed a diverse range of valid and reliable methods used to measure and describe professionalism in healthcare. Included studies utilized both qualitative and quantitative approaches and spanned various contexts, highlighting the adaptability and robustness of measurement techniques.

The findings underscore the critical role of professionalism in delivering quality care and fostering trust in healthcare settings. Employing multiple measurement approaches is essential for effectively assessing healthcare personnel's behaviour, ultimately enhancing trust and service quality.

本研究旨在探讨现有文献、关键概念和衡量卫生部门专业精神的战略方法。研究的核心问题是：如何在不同的医疗保健领域评估专业精神？专业精神对于医疗机构内的优质护理和信任至关重要。了解如何衡量可以提高医疗服务质量。本综述遵循JBI方法并遵循PRISMA-ScR指南进行。电子数据库系统地检索了2005年至2024年间发表的文章。共纳入1558篇文献，经标题和摘要筛选，共纳入44篇进行分析。回顾揭示了各种有效和可靠的方法用于测量和描述在医疗保健专业。纳入的研究利用了定性和定量方法，跨越了各种背景，突出了测量技术的适应性和稳健性。研究结果强调了专业精神在提供高质量护理和促进医疗机构信任方面的关键作用。采用多种测量方法对于有效评估医护人员的行为，最终提高信任和服务质量至关重要。

{"title":"How is professionalism measured in health care professions?","authors":"Anas Alnasser , Brett Williams , Cameron M Gosling","doi":"10.1016/j.hsr.2025.100224","DOIUrl":"10.1016/j.hsr.2025.100224","url":null,"abstract":"<div><div>This scoping study aims to explore the available literature, key concepts, and strategic approaches for measuring professionalism in the health sector. The central research question is: How is professionalism evaluated across various healthcare fields?</div><div>Professionalism is essential for quality care and trust within healthcare institutions. Understanding how it is measured can enhance healthcare delivery.</div><div>This review was conducted following the JBI approach and adhering to PRISMA-ScR guidelines.</div><div>Electronic databases were systematically searched for articles published between 2005 and 2024. A total of 1,558 articles were identified, and after screening titles and abstracts, 44 papers were included for analysis.</div><div>The review revealed a diverse range of valid and reliable methods used to measure and describe professionalism in healthcare. Included studies utilized both qualitative and quantitative approaches and spanned various contexts, highlighting the adaptability and robustness of measurement techniques.</div><div>The findings underscore the critical role of professionalism in delivering quality care and fostering trust in healthcare settings. Employing multiple measurement approaches is essential for effectively assessing healthcare personnel's behaviour, ultimately enhancing trust and service quality.</div></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"16 ","pages":"Article 100224"},"PeriodicalIF":0.0,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144195327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0